-
READ MOREJune 1, 2021 – Today we are very excited to announce that Jeff Moore has become one of our key investors, board members and has been appointed as the company’s Chief Operating Officer (COO)! Jeff will be taking over the management of key functions of the business including Sales, Marketing, Customer Support and more. Jeff […]
-
READ MOREMay 17, 2021 – Today we are very excited to announce that the beta version of the Divergence Neuro Platform is being made available to all pre-registered therapists and clinics! For months, the teams at Divergence have been working tirelessly to develop a platform for therapists, clinics and researchers to better connect and manage patient […]
-
READ MOREWe are pleased to announce that Dr. Sergio R. Pérez Rosal, (MD) has been appointed Special Advisor of Clinical and Scientific Research Affairs, providing expertise on the scientific research, clinical protocol design, and pharmacological guidance. Dr. Pérez works as a medical doctor at OVID Clinic Berlin and as MIND Academy director at the MIND Foundation. He […]
-
READ MOREMay 4, 2021 – We are excited to announce that Divergence was featured on the very first episode of Tech Talks! MPP and Ontario NDP Critic for Technology Development and Innovation, Chris Glover, has started a YouTube Mini Series called Tech Talks where he speaks with entrepreneurs, business leaders and others involved in the technology […]
-
READ MOREDivergence is thrilled to announce that it will be a crucial part of this collaboration that will bring deeply meaningful and substantive improvements to the lives of those afflicted with addiction. We are deeply humbled by the impact of Entheon’s mission and honoured to be part of the journey together. It is exciting to apply […]
